JOINN (Suzhou) accepted into the Polish OECD GLP program
2015-11-05
On 29th October 2015 JOINN (Suzhou) received a Good Laboratory Practice (GLP) Certificate Statement to confirm the company’s compliance with the OECD and EU principles of Good Laboratory Practice in the fields of Toxicology, Mutagenicity, Toxicokinetics, chemical analysis and Clinical Chemistry testing. The certification follows an extensive audit of JOINN’s facilities in August 2015 by the Polish Bureau of Chemical Substances and included facility standards, GLP systems, study management and data integrity. The inspection covered data audit from a range of studies within the scope of the Certificate. It means that data submitted to OECD countries will be automatically accepted under the OECD Mutual Acceptance of Data (MAD) scheme.
Dr Dylan Yao, Senior VP and Chief Scientific Officer, sees this certification as yet another endorsement of JOINN’s ever growing competence and capability, and as useful addition to the company’s already well certified activities. As the earliest established privately held Chinese preclinical CRO, JOINN has naturally been CFDA certified but has also been satisfactorily inspected by US FDA. The company has a long track record of GLP compliance. As strong believers in the value of high standards of laboratory animal welfare, JOINN is AAALAC accredited and utilizes animal caging systems that meet European standards.
Studies from JOINN are regularly submitted to both CFDA and US FDA. The addition of OECD certification will allow the company to extend its services to the growing number of sponsors who wish to submit data to OECD member countries.
With 20 years of operations since being founded in 1995, JOINN continues to focus on providing services for drug innovation and ultimately for the benefit of human society, utilizing our wide capability; extensive experience and unremitting efforts to provide clients with a one-stop and top quality service for the entire process of new drug development.
